Trade Verastem - VSTM CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Long position overnight fee | -0.0225% |
Short position overnight fee | -0.0219% |
Overnight fee time | 21:00 (UTC) |
Min traded quantity | 1 |
Currency | USD |
Margin | 20% |
Stock exchange | United States of America |
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 1.18 |
Open* | 1.2 |
Day's Range* | 1.2 - 1.2 |
1-Year Change* | -2.44% |
Volume | N/A |
Average Vol. (3m) | 37.4267 |
52 wk Range | N/A |
Market Cap | 238.516 |
P/E Ratio | N/A |
Shares Outstanding | 187808000 |
Revenue | 3.143 |
EPS | -0.43017 |
Dividend (Yield %) | N/A |
Beta | 0.80647 |
Next Earnings Date | Nov 2, 2022 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Aug 12, 2022 | 1.24 | 0.05 | 4.20% | 1.19 | 1.24 | 1.19 |
Aug 11, 2022 | 1.18 | -0.05 | -4.07% | 1.23 | 1.25 | 1.18 |
Aug 10, 2022 | 1.23 | 0.04 | 3.36% | 1.19 | 1.25 | 1.19 |
Aug 9, 2022 | 1.19 | -0.03 | -2.46% | 1.22 | 1.23 | 1.13 |
Aug 8, 2022 | 1.25 | 0.11 | 9.65% | 1.14 | 1.27 | 1.14 |
Aug 5, 2022 | 1.18 | 0.08 | 7.27% | 1.10 | 1.18 | 1.09 |
Aug 4, 2022 | 1.12 | 0.04 | 3.70% | 1.08 | 1.12 | 1.08 |
Aug 3, 2022 | 1.09 | 0.04 | 3.81% | 1.05 | 1.12 | 1.05 |
Aug 2, 2022 | 1.07 | 0.01 | 0.94% | 1.06 | 1.08 | 1.04 |
Aug 1, 2022 | 1.05 | 0.01 | 0.96% | 1.04 | 1.08 | 1.03 |
Jul 29, 2022 | 1.04 | -0.05 | -4.59% | 1.09 | 1.09 | 1.03 |
Jul 28, 2022 | 1.09 | -0.02 | -1.80% | 1.11 | 1.11 | 1.07 |
Jul 27, 2022 | 1.11 | 0.01 | 0.91% | 1.10 | 1.12 | 1.09 |
Jul 26, 2022 | 1.09 | -0.01 | -0.91% | 1.10 | 1.11 | 1.09 |
Jul 25, 2022 | 1.10 | -0.04 | -3.51% | 1.14 | 1.15 | 1.10 |
Jul 22, 2022 | 1.15 | -0.06 | -4.96% | 1.21 | 1.24 | 1.14 |
Jul 21, 2022 | 1.21 | 0.00 | 0.00% | 1.21 | 1.22 | 1.19 |
Jul 20, 2022 | 1.22 | 0.03 | 2.52% | 1.19 | 1.22 | 1.17 |
Jul 19, 2022 | 1.19 | 0.11 | 10.19% | 1.08 | 1.19 | 1.08 |
Jul 18, 2022 | 1.09 | 0.00 | 0.00% | 1.09 | 1.12 | 1.08 |
Verastem Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, November 2, 2022 | ||
10:59 | | Q3 2022 Verastem Inc Earnings Release |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 26.718 | 17.456 | 88.516 | 2.053 |
Total Operating Expense | 37.002 | 67.804 | 121.501 | 149.797 | 139.456 | 63.462 |
Selling/General/Admin. Expenses, Total | 17.223 | 21.381 | 77.265 | 101.212 | 58.655 | 24.115 |
Research & Development | 19.779 | 46.423 | 43.648 | 45.778 | 40.876 | 39.347 |
Operating Income | -37.002 | -67.804 | -94.783 | -132.341 | -50.94 | -61.409 |
Interest Income (Expense), Net Non-Operating | 0.562 | 0.002 | -3.207 | -16.227 | -15.279 | -9.791 |
Net Income Before Taxes | -36.44 | -67.802 | -72.434 | -149.209 | -67.532 | -71.2 |
Net Income After Taxes | -36.44 | -67.802 | -72.434 | -149.209 | -67.726 | -71.2 |
Net Income Before Extra. Items | -36.44 | -67.802 | -72.434 | -149.209 | -67.726 | -71.2 |
Net Income | -36.44 | -67.802 | -72.434 | -149.209 | -67.726 | -71.2 |
Income Available to Common Excl. Extra. Items | -36.44 | -67.802 | -72.434 | -149.209 | -67.726 | -71.2 |
Income Available to Common Incl. Extra. Items | -36.44 | -67.802 | -72.434 | -149.209 | -67.726 | -71.2 |
Diluted Net Income | -36.44 | -67.802 | -72.434 | -149.209 | -67.726 | -71.2 |
Diluted Weighted Average Shares | 36.988 | 38.422 | 64.962 | 74.578 | 153.33 | 174.406 |
Diluted EPS Excluding Extraordinary Items | -0.98518 | -1.76467 | -1.11502 | -2.00071 | -0.4417 | -0.40824 |
Diluted Normalized EPS | -0.98518 | -1.76467 | -1.11502 | -2.04362 | -0.4155 | -0.40801 |
Revenue | 26.718 | 17.456 | 88.516 | 2.053 | ||
Cost of Revenue, Total | 0.165 | 1.238 | 32.952 | 0 | ||
Gross Profit | 26.553 | 16.218 | 55.564 | 2.053 | ||
Depreciation / Amortization | 0.423 | 1.569 | 0.793 | 0 | ||
Other, Net | 25.556 | -0.641 | -1.313 | 0 | ||
Unusual Expense (Income) | 6.18 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total revenue | 1.006 | 0.5 | 0.002 | 0.545 | 2.596 |
Revenue | 1.006 | 0.5 | 0.002 | 0.545 | 2.596 |
Cost of Revenue, Total | 0 | 0 | 0 | 0 | |
Gross Profit | 1.006 | 0.5 | 0.002 | 0.545 | |
Total Operating Expense | 15.114 | 16.444 | 14.848 | 17.056 | 19.576 |
Selling/General/Admin. Expenses, Total | 6.218 | 6.714 | 5.523 | 5.66 | 5.934 |
Research & Development | 8.896 | 9.73 | 9.325 | 11.396 | 13.642 |
Depreciation / Amortization | 0 | 0 | 0 | 0 | |
Operating Income | -14.108 | -15.944 | -14.846 | -16.511 | -16.98 |
Interest Income (Expense), Net Non-Operating | -0.923 | -0.958 | -7.94 | 0.03 | -0.01 |
Net Income Before Taxes | -15.031 | -16.902 | -22.786 | -16.481 | -16.962 |
Net Income After Taxes | -15.031 | -16.902 | -22.786 | -16.481 | -16.962 |
Net Income Before Extra. Items | -15.031 | -16.902 | -22.786 | -16.481 | -16.962 |
Net Income | -15.031 | -16.902 | -22.786 | -16.481 | -16.962 |
Income Available to Common Excl. Extra. Items | -15.031 | -16.902 | -22.786 | -16.481 | -16.962 |
Income Available to Common Incl. Extra. Items | -15.031 | -16.902 | -22.786 | -16.481 | -16.962 |
Diluted Net Income | -15.031 | -16.902 | -22.786 | -16.481 | -16.962 |
Diluted Weighted Average Shares | 171.586 | 171.985 | 179.861 | 174.052 | 186.264 |
Diluted EPS Excluding Extraordinary Items | -0.0876 | -0.09828 | -0.12669 | -0.09469 | -0.09106 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.0876 | -0.09828 | -0.12646 | -0.09469 | -0.09106 |
Other, Net | 0 | 0 | 0 | 0.028 | |
Unusual Expense (Income) | 0 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 81.295 | 87.787 | 253.259 | 84.961 | 144.938 | 105.74 |
Cash and Short Term Investments | 80.897 | 86.672 | 249.653 | 75.506 | 141.226 | 100.256 |
Cash & Equivalents | 32.349 | 82.176 | 129.867 | 43.514 | 67.782 | 21.252 |
Short Term Investments | 48.548 | 4.496 | 119.786 | 31.992 | 73.444 | 79.004 |
Total Receivables, Net | 0.204 | 0.306 | 2.524 | 0.239 | 0.516 | |
Prepaid Expenses | 0.194 | 1.115 | 2.973 | 3.835 | 3.473 | 4.968 |
Total Assets | 83.629 | 89.791 | 277.236 | 145.046 | 154.349 | 108.662 |
Property/Plant/Equipment, Total - Net | 1.417 | 0.861 | 1.369 | 4.024 | 3.142 | 2.512 |
Property/Plant/Equipment, Total - Gross | 3.616 | 3.616 | 1.878 | 4.962 | 4.611 | 4.187 |
Accumulated Depreciation, Total | -2.199 | -2.755 | -0.509 | -0.938 | -1.469 | -1.675 |
Other Long Term Assets, Total | 0.917 | 1.143 | 1.031 | 36.053 | 0.274 | 0.41 |
Total Current Liabilities | 10.991 | 17.128 | 37.077 | 29.89 | 17.093 | 18.59 |
Accounts Payable | 4.095 | 9.186 | 10.253 | 9.655 | 1.875 | 2.302 |
Accrued Expenses | 6.721 | 7.752 | 21.108 | 19.785 | 15.218 | 16.288 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.175 | 0.19 | 0.45 | 0 | ||
Total Liabilities | 11.332 | 32.107 | 152.937 | 137.872 | 39.075 | 21.103 |
Total Long Term Debt | 0 | 14.828 | 114.737 | 103.623 | 19.051 | 0.249 |
Other Liabilities, Total | 0.341 | 0.151 | 1.123 | 4.359 | 2.931 | 2.264 |
Total Equity | 72.297 | 57.684 | 124.299 | 7.174 | 115.274 | 87.559 |
Common Stock | 0.004 | 0.005 | 0.007 | 0.008 | 0.017 | 0.019 |
Additional Paid-In Capital | 307.587 | 360.823 | 499.741 | 531.937 | 707.715 | 751.217 |
Retained Earnings (Accumulated Deficit) | -235.323 | -303.142 | -375.576 | -524.785 | -592.511 | -663.711 |
Other Equity, Total | 0.029 | -0.002 | 0.127 | 0.014 | 0.053 | 0.034 |
Total Liabilities & Shareholders’ Equity | 83.629 | 89.791 | 277.236 | 145.046 | 154.349 | 108.662 |
Total Common Shares Outstanding | 36.992 | 50.801 | 73.806 | 80.118 | 170.456 | 185.286 |
Long Term Debt | 14.828 | 114.737 | 103.623 | 19.051 | 0.249 | |
Accounts Receivable - Trade, Net | 0.306 | 2.524 | 0.239 | 0.516 | ||
Total Inventory | 0.327 | 3.096 | 0 | |||
Intangibles, Net | 21.577 | 20.008 | 0 | |||
Current Port. of LT Debt/Capital Leases | 5.716 | 0 | ||||
Long Term Investments | 5.995 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 127.678 | 114.76 | 108.757 | 105.74 | 113.439 |
Cash and Short Term Investments | 121.097 | 108.135 | 103.416 | 100.256 | 106.278 |
Cash & Equivalents | 35.514 | 24.972 | 24.314 | 21.252 | 46.687 |
Short Term Investments | 85.583 | 83.163 | 79.102 | 79.004 | 59.591 |
Total Receivables, Net | 1.125 | 0.476 | 0.105 | 0.516 | 2.644 |
Accounts Receivable - Trade, Net | 1.125 | 0.476 | 0.105 | 0.516 | 2.644 |
Prepaid Expenses | 5.456 | 6.149 | 5.236 | 4.968 | 4.517 |
Total Assets | 136.901 | 123.89 | 111.877 | 108.662 | 116.148 |
Property/Plant/Equipment, Total - Net | 2.963 | 2.794 | 2.656 | 2.512 | 2.363 |
Long Term Investments | 5.998 | 5.992 | 0 | 0 | |
Other Long Term Assets, Total | 0.262 | 0.344 | 0.464 | 0.41 | 0.346 |
Total Current Liabilities | 11.844 | 12.744 | 13.536 | 18.59 | 16.886 |
Accounts Payable | 2.453 | 1.395 | 0.641 | 2.302 | 2.896 |
Accrued Expenses | 9.391 | 11.349 | 12.895 | 16.288 | 13.99 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 34.292 | 35.685 | 16.222 | 21.103 | 43.377 |
Total Long Term Debt | 19.672 | 20.326 | 0.243 | 0.249 | 24.412 |
Long Term Debt | 19.672 | 20.326 | 0.243 | 0.249 | 24.412 |
Other Liabilities, Total | 2.776 | 2.615 | 2.443 | 2.264 | 2.079 |
Total Equity | 102.609 | 88.205 | 95.655 | 87.559 | 72.771 |
Common Stock | 0.017 | 0.017 | 0.018 | 0.019 | 0.019 |
Additional Paid-In Capital | 710.1 | 712.593 | 742.84 | 751.217 | 753.538 |
Retained Earnings (Accumulated Deficit) | -607.542 | -624.444 | -647.23 | -663.711 | -680.673 |
Other Equity, Total | 0.034 | 0.039 | 0.027 | 0.034 | -0.113 |
Total Liabilities & Shareholders’ Equity | 136.901 | 123.89 | 111.877 | 108.662 | 116.148 |
Total Common Shares Outstanding | 171.731 | 172.077 | 182.155 | 185.286 | 186.33 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | -36.44 | -67.802 | -72.434 | -149.209 | -67.726 | -71.2 |
Cash From Operating Activities | -29.484 | -57.31 | -74.515 | -138.518 | -33.506 | -53.502 |
Cash From Operating Activities | 0.67 | 0.556 | 0.996 | 0.429 | 0.531 | 0.206 |
Non-Cash Items | 6.147 | 5.256 | -17.15 | 16.492 | 21.261 | 16.908 |
Cash Interest Paid | 0 | 0.295 | 2.107 | 12.424 | 5.126 | 1.007 |
Changes in Working Capital | 0.139 | 4.68 | 13.65 | -7.799 | 11.635 | 0.584 |
Cash From Investing Activities | 36.927 | 43.953 | -138.377 | 89.613 | -47.363 | 0.087 |
Capital Expenditures | -0.039 | 0 | -23.507 | -0.007 | -0.033 | -0.196 |
Other Investing Cash Flow Items, Total | 36.966 | 43.953 | -114.87 | 89.62 | -47.33 | 0.283 |
Cash From Financing Activities | -0.005 | 63.184 | 261.162 | -2.441 | 69.63 | 6.885 |
Financing Cash Flow Items | -0.005 | -0.138 | -0.506 | -2.048 | -0.925 | |
Issuance (Retirement) of Stock, Net | 0 | 48.511 | 105.965 | 0.569 | 109.044 | 7.81 |
Issuance (Retirement) of Debt, Net | 0 | 14.811 | 155.197 | -2.504 | -37.366 | 0 |
Net Change in Cash | 7.438 | 49.827 | 48.27 | -51.346 | -11.239 | -46.53 |
Amortization | 0.423 | 1.569 | 0.793 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.031 | -31.933 | -54.719 | -71.2 | -16.962 |
Cash From Operating Activities | -19.318 | -32.742 | -43.569 | -53.502 | -19.281 |
Cash From Operating Activities | 0.081 | 0.146 | 0.176 | 0.206 | 0.03 |
Non-Cash Items | 2.584 | 5.416 | 15.326 | 16.908 | 1.626 |
Cash Interest Paid | 0 | 0 | 0 | 0 | |
Changes in Working Capital | -6.952 | -6.371 | -4.352 | 0.584 | -3.975 |
Cash From Investing Activities | -12.372 | -9.979 | 0.021 | 0.087 | 19.264 |
Capital Expenditures | -0.196 | -0.196 | -0.196 | -0.196 | 0 |
Other Investing Cash Flow Items, Total | -12.176 | -9.783 | 0.217 | 0.283 | 19.264 |
Cash From Financing Activities | -0.578 | -0.089 | 0.08 | 6.885 | 25.452 |
Financing Cash Flow Items | -0.878 | -0.907 | -0.999 | -0.925 | 0 |
Issuance (Retirement) of Stock, Net | 0.3 | 0.818 | 1.079 | 7.81 | 0.68 |
Net Change in Cash | -32.268 | -42.81 | -43.468 | -46.53 | 25.435 |
Amortization | 0 | 0 | 0 | ||
Issuance (Retirement) of Debt, Net | 0 | 24.772 |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Verastem Company profile
VerastemIndustry: | Bio Therapeutic Drugs |
117 Kendrick St Ste 500
CAMBRIDGE
MASSACHUSETTS 02142
US
Income statement
News

Indonesia clears 400 cryptocurrencies for local traders
Government says it is now legal to trade over 380 crypto assets with crypto exchanges
03:22, 15 August 2022
Women in crypto: Valour CSO Diana Biggs cracks glass ceiling
Executive manages company’s venture-capital portfolio and grows ETP business
03:17, 15 August 2022
Crypto market wrap: Sector treads water amid choppy trading
On average, digital coin prices remain flat as challenging week concludes
21:16, 12 August 2022
Mexico's Pemex requests $6.5 bln more funding for 'Dos Bocas' refinery -documents, source
Adds detail
19:26, 12 August 2022
3M demerger: MMM spin off Food Safety Business SpinCo merger with Neogen timing and details in full
3M (MMM) has revealed further details about its $5.3bn scheme to spin off its food-safety business. Added to the demerger of its health care products division, 3M is taking steps to lift its stock price.
19:21, 12 August 2022People Also Watch
Ripple to US Dollar
Long position overnight fee | -0.0500% |
Short position overnight fee | 0.0140% |
Overnight fee time | 21:00 (UTC) |
Spread | 0.00600 |
Still looking for a broker you can trust?
Join the 427.000+ traders worldwide that chose to trade with Capital.com